RetiSpec
Noninvasive Eye Scan to Detect Alzheimer's Disease
StartupRetiSpec is a Ramat Gan-based startup in the Health Tech & Life Sciences sector, established in 2016. Noninvasive Eye Scan to Detect Alzheimer's Disease. The company has raised a total of $13.55M across 5 funding rounds, currently at the A stage. RetiSpec was founded by Roy Kirshon. Key investors include iGan Partners, Gentex Corporation, Verge HealthTech Fund, among 4 total investors. The company has 11-50 employees. Core technologies: Artificial Intelligence, Image Recognition, Machine Learning.
With $13.55M in total funding, RetiSpec is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2B/B2C business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageA
- ProductClinical Trial
- ModelB2B, B2C
- Employees11-50
- HQRamat Gan
- DistrictCenter District
- Last Round$10M
- iGan PartnersLead
- Gentex Corporation
- Verge HealthTech Fund
4 investors total
Roy KirshonCo-founder & COO
11 articles covered by sources including www.prnewswire.com,
braininstitute.ca,
www.newswire.ca,
worlddementiacouncil.org,
www.everythingzoomer.com.
What does RetiSpec do?
RetiSpec is a medical imaging company developing a tool for the early detection of Alzheimer's disease biomarkers in the eye. The company's goal is to enable the widespread early detection of Alzheimer's disease through accessible and scalable screening. Through a quick eye exam, RetiSpec opens a window of opportunity for timely and specific therapeutic interventions so that the progression of the disease can be slowed or even prevented. The company's patented technology harnesses hyperspectral imagery in synergy with machine learning to allow for rapid, simple, and cost-effective identification of Alzheimer's biomarkers years before the emergence of clinical symptoms. RetiSpec uses computer vision and machine-learning algorithms to detect the unique signatures of Alzheimer's biomarkers in seconds.
How much funding has RetiSpec raised?
RetiSpec has raised $13.55M in total funding across 5 rounds. The company is currently at the A stage. Key investors include iGan Partners, Gentex Corporation, Verge HealthTech Fund.
Who founded RetiSpec?
RetiSpec was founded in 2016 by Roy Kirshon (Co-founder & COO).
What sector is RetiSpec in?
RetiSpec operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, with core technologies in Artificial Intelligence, Image Recognition, Machine Learning. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is RetiSpec located?
RetiSpec is based in Derech Sheba 2, Ramat Gan, Israel, Center District. The company also has offices abroad.